IFNβ drives ferroptosis through elevating TRIM22 and promotes the cytotoxicity of RSL3

Huiyue Dong1,2, Ling Zhu1,2, Jingjing Sun1,3

  • 1Fujian Provincial Key Laboratory of Transplant Biology, Dongfang Hospital (the 900th Hospital of Joint Logistic Support Force), Xiamen University, Fuzhou, China.

Frontiers in Immunology
|February 20, 2025
PubMed
Abstract

Insights

Interferon-beta (IFNβ) promotes ferroptosis, a form of cell death, by increasing iron and lipid peroxidation in tumor cells. Combining IFNβ with RSL3 enhances anti-tumor effects, suggesting a potential therapeutic strategy.

Area of Science:

  • Immunology
  • Cell Biology
  • Oncology

Background:

  • The cyclic GMP-AMP synthase (cGAS)-stimulator-of-interferon genes (STING) pathway senses cytosolic DNA.
  • Interferon-beta (IFNβ), a product of this pathway, can suppress tumor growth.
  • The role of ferroptosis in IFNβ-induced cell death remained unclear.

Purpose of the Study:

  • To investigate the effects of IFNβ on ferroptosis in tumor cells.
  • To elucidate the molecular mechanisms underlying IFNβ-induced ferroptosis.
  • To evaluate the potential of combining IFNβ with ferroptosis-inducing agents for cancer therapy.

Main Methods:

  • IFNβ treatment and ferroptosis analysis in multiple cancer cell lines (HT1080, 4T1, HCT116, 786-O).
  • RNA-sequencing to analyze transcriptomic changes induced by IFNβ.
  • Gene silencing (siRNA) of STAT1, STAT3, TRIM21, and TRIM22 to assess their roles.
  • In vivo studies using cGAS-STING pathway-activated mice and xenograft models.
  • Combination therapy studies with IFNβ and RSL3 (a ferroptosis inducer).

Main Results:

  • IFNβ increased intracellular iron (Fe²⁺) and lipid peroxidation, while decreasing glutathione (GSH) levels in tumor cells.
  • RNA-seq revealed IFNβ-induced alterations in ferroptosis-related gene expression.
  • Knockdown of tripartite motif-containing 22 (TRIM22) reversed IFNβ-induced changes in Fe²⁺, lipid ROS, heme oxygenase (HMOX1), and ferroptosis suppressor protein 1 (FSP1).
  • IFNβ enhanced RSL3-induced ferroptosis and inhibited GPX4 activity.
  • Combined IFNβ and RSL3 treatment significantly inhibited tumor growth in 3D spheroids and xenograft models.

Conclusions:

  • IFNβ actively promotes ferroptosis in tumor cells.
  • TRIM22 plays a crucial role in mediating IFNβ-induced ferroptosis.
  • The combination of IFNβ and RSL3 demonstrates enhanced anti-tumor efficacy, suggesting a promising therapeutic strategy.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.0K